Impact of SLCO1B3 single nucleotide polymorphisms (SNPs) on outcomes in patients with castration resistant prostate cancer (CRPC) treated with docetaxel.

被引：0
|
作者：
Tripathi, Abhishek
Xie, Wanling
Sweeney, Christopher
Choudhury, Atish Dipankar
Pomerantz, Mark
Wei, Xiao X.
Taplin, Mary-Ellen
Choueiri, Toni K.
Lee, Gwo-Shu Mary
Kantoff, Philip W.
Harshman, Lauren Christine
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e17027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17027
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes
    Wright, Jonathan L.
    Kwon, Erika M.
    Ostrander, Elaine A.
    Montgomery, R. Bruce
    Lin, Daniel W.
    Vessella, Robert
    Stanford, Janet L.
    Mostaghel, Elahe A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (04) : 619 - 627
  • [2] Association between genetic polymorphisms in SLCO1B3 gene and response to ketoconazole (K) in men with castration-resistant prostate cancer (CRPC)
    Taplin, M.
    Nakabayashi, A.
    Werner, L.
    Yang, M.
    Xie, W.
    Sun, T.
    Pomerantz, M.
    Freedman, M.
    Lee, G. M.
    Kantoff, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Identification of novel single nucleotide polymorphisms (SNPs) associated with risk and prognosis in patients with castration-resistant prostate cancer (CRPC)
    Sissung, Tristan M.
    John, Deeken
    Leibrand, Crystal R.
    Price, Douglas K.
    Ehrlich, Sheryl
    Steinberg, Seth M.
    Liewehr, David J.
    Dahut, William L.
    Figg, William D.
    CANCER RESEARCH, 2016, 76
  • [4] The Effects of ABCC2 and SLCO1B3 Single Nucleotide Polymorphisms on Docetaxel-Induced Leukopenia in Breast Cancer Patients.
    Chen, J.
    Wu, L. J.
    Shen, P.
    Yu, L. F.
    Huang, S.
    CANCER RESEARCH, 2011, 71
  • [5] THE INFLUENCE OF SLCO1B3 POLYMORPHISMS ON DOCETAXEL DISPOSITION IN ASIAN NASOPHARYNGEAL CARCINOMA PATIENTS
    Chew, S.
    Mann, O.
    Ramasamy, R.
    Lim, W.
    Tan, E.
    Lee, E. J.
    Chowbay, B.
    ANNALS OF ONCOLOGY, 2010, 21 : 52 - 52
  • [6] The Role of PCA 3 as a Prognostic Factor in Patients with Castration-resistant Prostate Cancer (CRPC) Treated with Docetaxel
    Bourdoumis, Andreas
    Chrisofos, Michael
    Stasinou, Theodora
    Christopoulos, Panagiotis
    Mourmouris, Panagiotis
    Kostakopoulos, Athanasios
    Deliveliotis, Charalambos
    ANTICANCER RESEARCH, 2015, 35 (05) : 3075 - 3079
  • [7] Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients
    Chew, Sin Chi
    Sandanaraj, Edwin
    Singh, Onkar
    Chen, Xiangai
    Tan, Eng Huat
    Lim, Wan Teck
    Lee, Edmund J. D.
    Chowbay, Balram
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (04) : 606 - 618
  • [8] Exosomal cancer-type SLCO1B3 and ABCC3 as potential biomarkers of castration resistant prostate cancer
    Beatson, Erica L.
    Lee, Kristi Y.
    Knechel, Martina A.
    Sommer, Elijah R.
    Depaz, Roger
    Risdon, Emily N.
    Leon, Andres F.
    Strope, Jonathan D.
    Price, Douglas K.
    Chau, Cindy H.
    Figg, William D.
    CANCER RESEARCH, 2023, 83 (11)
  • [9] Survival outcomes among metastatic castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitor and docetaxel.
    Hwang, Yunji
    Wheeling, Travis
    Hatfield, Mark
    Kim, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [10] Single nucleotide polymorphisms (SNPs) as predictors of efficacy of cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Herrero Rivera, Daniel
    Duran, Ignacio
    Marcos Kovandzic, Laura
    Puente, Javier
    Mellado, Begona
    Grande, Enrique
    Antonio Virizuela, Juan
    Francisco Rodriguez-Moreno, Juan
    Azueta, Ainara
    Alonso Buznego, Lucia Andrea
    Luque, Raquel
    Garrigos, Carmen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345